ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,037.59
      1.06%
      US Tech 100
      21,148.00
      -0.24%
      Dow Jones
      43,325.80
      0.07%
      Brent Oil
      72.89
      0.00%
      Bitcoin
      95,603.65
      -0.09%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cartesian Therapeutics Inc (RNAC) Quote

      Cartesian Therapeutics Inc

      Cartesian Therapeutics Inc (RNAC)

      NASDAQ
      19.88
      1.41
      (7.63%)
      At close: December 26 4:00PM
      Delayed by 15 minutes
      19.88
      -0.04
      ( -0.20% )
      After Hours: 5:37PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      19.88
      Bid
      16.70
      Ask
      21.50
      Volume
      39,754
      18.27 Day's Range 19.97
      11.665 52 Week Range 41.87
      Market Cap
      505.248M
      Previous Close
      18.47
      Open
      18.27
      Last Trade
      1
      @
      19.09
      Last Trade Time
      16:30:49
      Financial Volume
      $ 774,715
      VWAP
      19.4877
      Average Volume (3m)
      132,033
      Shares Outstanding
      25,414,898
      Dividend Yield
      -
      PE Ratio
      -2.30
      Earnings Per Share (EPS)
      -8.64
      Revenue
      26M
      Net Profit
      -219.71M

      About Cartesian Therapeutics Inc

      Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.selectabio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $18.47. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 41.87.

      Cartesian Therapeutics currently has 25,414,898 shares outstanding. The market capitalization of Cartesian Therapeutics is $469.41 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -2.30.

      Ask ADVFN Intelligence (AI)

      RNAC Latest News

      More News

      Cartesian Therapeutics Announces New Employment Inducement Grants

      FREDERICK, Md., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the...

      December 18 2024
      GlobeNewswire Inc.

      Form S-3 - Registration statement under Securities Act of 1933

      December 13 2024
      Edgar (US Regulatory)

      Form S-3 - Registration statement under Securities Act of 1933

      December 13 2024
      Edgar (US Regulatory)

      Form S-3 - Registration statement under Securities Act of 1933

      December 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 10 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 09 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 03 2024
      Edgar (US Regulatory)

      Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

      Phase 3 AURORA trial on track to commence in 1H2025; Primary endpoint to assess proportion of Descartes-08-treated participants with myasthenia gravis demonstrating an MG-ADL improvement of ≥3...

      December 03 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 21 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.799.8949695964618.0920.29516.727085919.06298915CS
      41.699.2908191313918.1926.516.716599020.19206375CS
      121.977411.045323025717.902626.515.513203320.28402562CS
      26-4.03-16.854872438323.9129.6512.4813682618.39082175CS
      52-2.17-9.8412698412722.0541.8711.66528218820.29685942CS
      156-4.315-17.834263277524.19542.611.66537391022.70545953CS
      260-4.315-17.834263277524.19542.611.66537391022.70545953CS

      RNAC - Frequently Asked Questions (FAQ)

      What is the current Cartesian Therapeutics share price?
      The current share price of Cartesian Therapeutics is $ 19.88
      How many Cartesian Therapeutics shares are in issue?
      Cartesian Therapeutics has 25,414,898 shares in issue
      What is the market cap of Cartesian Therapeutics?
      The market capitalisation of Cartesian Therapeutics is USD 469.41M
      What is the 1 year trading range for Cartesian Therapeutics share price?
      Cartesian Therapeutics has traded in the range of $ 11.665 to $ 41.87 during the past year
      What is the PE ratio of Cartesian Therapeutics?
      The price to earnings ratio of Cartesian Therapeutics is -2.3
      What is the cash to sales ratio of Cartesian Therapeutics?
      The cash to sales ratio of Cartesian Therapeutics is 19.47
      What is the reporting currency for Cartesian Therapeutics?
      Cartesian Therapeutics reports financial results in USD
      What is the latest annual turnover for Cartesian Therapeutics?
      The latest annual turnover of Cartesian Therapeutics is USD 26M
      What is the latest annual profit for Cartesian Therapeutics?
      The latest annual profit of Cartesian Therapeutics is USD -219.71M
      What is the registered address of Cartesian Therapeutics?
      The registered address for Cartesian Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Cartesian Therapeutics website address?
      The website address for Cartesian Therapeutics is www.selectabio.com
      Which industry sector does Cartesian Therapeutics operate in?
      Cartesian Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TOIIWOncology Institute Inc
      $ 0.0197
      (109.57%)
      		42.81k
      EVAXEvaxion Biotech AS
      $ 1.64
      (93.85%)
      		7.03M
      INTZIntrusion Inc
      $ 0.8011
      (78.02%)
      		3.71M
      KITTNauticus Robotics Inc
      $ 2.6799
      (50.56%)
      		6.04M
      RVSNRail Vision Ltd
      $ 1.15
      (48.66%)
      		7.84M
      MITAColiseum Acquisition Corporation
      $ 9.00
      (-21.81%)
      		11.96k
      BDRXBiodexa Pharmaceuticals PLC
      $ 4.04
      (-14.04%)
      		4.42k
      CTCXCarmell Corporation
      $ 0.285
      (-11.49%)
      		163.45k
      SPRCSciSparc Ltd
      $ 0.4464
      (-10.72%)
      		2.09M
      DOMHDominari Holdings Inc
      $ 1.11
      (-10.48%)
      		3.06k
      CRKNCrown Electrokinetics Corporation
      $ 0.16
      (21.49%)
      		38.06M
      OMEXOdyssey Marine Exploration Inc
      $ 0.61
      (26.95%)
      		9.82M
      QSIQuantum Si Inc
      $ 2.63
      (22.33%)
      		9.26M
      XTIAXTI Aerospace Inc
      $ 0.03995
      (-0.13%)
      		8.28M
      RVSNRail Vision Ltd
      $ 1.15
      (48.66%)
      		7.84M

      Discussion

      View Full Feed
      manibiotech manibiotech 5 minutes ago
      Exactly
      That's why I was surprised and disappointed at the talk about 50M option . The financier will have a field day buying 10s of millions of shares on cheap if the option is exercised in my opinion . 
      If they were going to get a substantial upfront cash on any negotiated deal soon
      NWBO
      weedtrader420 weedtrader420 5 minutes ago
      HBAR AEYE👁️
      AEYE
      aBeezlee aBeezlee 5 minutes ago
      Insane action...wish I bought more under 2. Get paid next week thankfully.
      MVST
      nwtf nwtf 5 minutes ago
      Wrong as usual. I started by quest for financial independence long before ERHC entered my life. ERHC at the time was just and issue I took a flyer on. First purchase was at .86. Sold when it dropped and then swing traded it and made some good money. And no this was and never has been an investment
      ERHE
      Tr8dervic Tr8dervic 5 minutes ago
      Results of 12/24/24 MM and 1-Play Deduction>>

      Mega Million numbers for 12/24/2024 are:

      11 14 38 45 46 Mega Ball 03
      Megaplier is 3

      There was no Jackpot Winner

      The estimated Jackpot was $1.0 Billion ( $448.8 Million cash).
      jbog jbog 5 minutes ago
      dewophile,

      You have to question why Enta had all this data and created a drug that's sitting in a broom closet while PFE turned it into a $75 Billion dollar product.
      PFE
      georgie18 georgie18 6 minutes ago
      ASST...51...🥳8k ...https://www.otcmarkets.com/filing/html?id=18070903&guid=lKY-kHdxdv3Th3h

      georgie18

      Member Level
      Re: georgie18 post# 667573

      Thursday, December 19, 2024 2:11:34 PM

      Post#
      668356
      of 669097
      ASST
      georgie18 georgie18 6 minutes ago
      ASST...51...🥳8k ...https://www.otcmarkets.com/filing/html?id=18070903&guid=lKY-kHdxdv3Th3h

      georgie18

      Member Level
      Re: georgie18 post# 667573

      Thursday, December 19, 2024 2:11:34 PM

      Post#
      668356
      of 669097
      georgie18 georgie18 7 minutes ago
      ASST...51...🥳8k ...https://www.otcmarkets.com/filing/html?id=18070903&guid=lKY-kHdxdv3Th3h

      georgie18

      Member Level
      Re: georgie18 post# 667573

      Thursday, December 19, 2024 2:11:34 PM

      Post#
      668356
      of 669097
      tw0122 tw0122 9 minutes ago
      $2.90

      AMBO
      Penny Stocks 2.0 Penny Stocks 2.0 12 minutes ago
      *MUST READ DD COMPILATION HUGE*$HLLK like $AB*T and $BC*S will rise to multi pennyland before you know it. 
      $AB*T ran over 1,000% in 2 weeks
      $BC*S ran 700% in under 2 weeks

      $HLLK is destined for a Massive run. My call is $0.02 to $0.05 short term, and long-term $0.10+
      AB BC HLLK
      PickStocks PickStocks 12 minutes ago
      Maybe you should ask Cactus for more information.....have tell you another story of soon......
      COOP
      janice shell janice shell 12 minutes ago
      Those people are going to learn a hard lesson. But really, where on earth did they get the idea that Trump has "common sense"??
      Penny Stocks 2.0 Penny Stocks 2.0 12 minutes ago
      *MUST READ DD COMPILATION HUGE*$HLLK like $AB*T and $BC*S will rise to multi pennyland before you know it. 
      $AB*T ran over 1,000% in 2 weeks
      $BC*S ran 700% in under 2 weeks

      $HLLK is destined for a Massive run. My call is $0.02 to $0.05 short term, and long-term $0.10+
      AB BC HLLK
      Bubae Bubae 12 minutes ago
      Outstanding share count update today. As usual backdated, this time to December 13th. The definitive 14C for the authorized share count increase to 6 billion shares was filed on December 17th so it didn't show up with this update. The November 29th update revealed an increase of 60,200,000 which wou
      BEGI
      tw0122 tw0122 12 minutes ago
      One more time
      AMBO
      Teliz2009 Teliz2009 12 minutes ago
      So surprised these guys rarely used the Wrap and eventually tanked the program 😂
      https://www.instagram.com/reel/DD8mt4FRJuH/?igsh=NTc4MTIwNjQ2YQ==
      WRAP
      Penny Stocks 2.0 Penny Stocks 2.0 12 minutes ago


      AB ABIT BC
      manibiotech manibiotech 13 minutes ago
      From ChatGPT

      NWBO
      bb8675309 bb8675309 14 minutes ago
      Also SEC needs to monitor all trading transactions on this stock. New SEC chairman coming soon. Can't wait.
      AVXL
      gitreal gitreal 14 minutes ago
      For me 2025 is the year for NBRI to shine above most in this off the chart precious metals market!!!

      So you invest in a serial securities fraud? Very clever indeed!!
      NBRI
      oldstocks oldstocks 14 minutes ago
      At this point Affluence Corp has lost control of the unrestricted shares as they out number the restricted shares.
      Unrestricted shares are in the retail hands.
      Retail should at this point have a controlling vote if anything were to be voted on.
      Whoever the majority shareholder
      AFFU
      EmpressMonk25 EmpressMonk25 15 minutes ago
      Just to put my speculation to work if you're going to...

      $5000 today buys 6,250,000 shares

      If company fully dilutes 50B shares and company does 1 for 500 RS, the new outstanding would be 100M

      New holdings after RS 12,500 shares

      $4 stock pri
      HMBL
      Hopeforthefuture3 Hopeforthefuture3 15 minutes ago
      Good one - lol! Merck I believe spent many $ on buying into some company with a phase 1 trial, too bad did not send a few millions to nwbo.
      I do hope Merck buys nwbo as can explore the potential of dcvax a.d direct in a timely fashion
      No year+ to write a SAP and another year to make a
      NWBO
      getmoreshares getmoreshares 15 minutes ago
      most of us are angles! couple devils show up now and then.
      CGAC

      Your Recent History

      NASDAQ
      RNAC
      Cartesian Therapeutics
      BIT
      F25174
      Vontobel Financial Produ...
      BIT
      F20809
      Vontobel Financial Produ...
      LSE
      ENSI
      Ensilica
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads